Vives Fund

VIVES is a technology-focused seed and early-stage investment fund initiated by UCLouvain and managed by VIVES Partners. It backs high-tech companies built on strong intellectual property and disruptive technologies, with a stated focus on ventures that can create positive societal impact. The fund invests across sectors, with particular emphasis on life sciences, AgTech and hard engineering, and it supports companies from seed through startup and growth stages. The fund positions itself as a hands-on partner rather than a purely financial investor. Its team says it helps founders challenge and refine their project, build governance from scratch, connect with professionals and investors, and prepare for long-term development and quality exits. VIVES mainly invests in European companies, with a preference for neighboring countries to Belgium, and it often co-invests alongside other investors. Key Offerings Seed and early-stage equity investment : VIVES provides capital investments from €100,000 up to €7,000,000 per investment line for young high-tech companies. It supports projects from pre-seed and seed through startup and growth, depending on the company’s maturity. Lead-investor and syndication support : The fund can act as lead investor and coordinate syndicated transactions with other investors. This helps companies assemble a broader shareholder base aligned on long-term development. Portfolio support and company building : Beyond funding, VIVES helps founders structure governance, validate the business against the market, and connect with experts, partners and investors. The fund presents itself as a close partner throughout development. University spin-off financing : VIVES specifically supports spin-offs from UCLouvain and partner universities, helping translate academic research into commercial ventures. Core Values Disruptive innovation : VIVES seeks companies built around breakthrough technologies that solve real market needs. Its investment thesis centers on innovation that can create new categories or materially improve existing ones. Positive societal impact : The fund explicitly looks for projects with a positive societal impact and integrates ESG considerations into its investment process. It aims to back businesses that contribute to long-term value beyond financial returns. Long-term partnership : VIVES emphasizes continuity, credibility and durable shareholder alignment. It aims to support companies over time and to favor quality exits that respect all stakeholders. Responsible investing : ESG criteria are part of the selection and monitoring process, including environmental, social and governance factors. The fund says it encourages portfolio companies to strengthen their ESG practices over time. Unique Aspects University-origin platform : VIVES was initiated by UCLouvain and has a long-standing role in turning university research into investable companies. That academic origin is central to its sourcing and positioning. Broad European university network : Through VIVES IUF, the fund has links with UCLouvain, KU Leuven, the University of Paris, Wageningen University and the University of Luxembourg. This gives it access to a recurring flow of research-driven opportunities. Established fund track record : The website states that VIVES has been investing for more than 15 years across technology sectors. Earlier funds include VIVES I (€15 million) and VIVES II (€43 million), while VIVES IUF reached €70 million after its second closing in 2024. Active portfolio support model : Testimonials on the site describe VIVES as an incubator-like partner that helps with equity structuring, stakeholder introductions and access to biotech and academic expertise. This suggests a notably hands-on approach to portfolio building.